Clinical and biochemical characterisation of patients with autosomal recessive hypercholesterolemia (ARH)

R Fellin1, G Zuliani, M Arca

  • 1Second Department of Internal Medicine, University of Ferrara, Ferrara, Italy. flr@unife.it

Insights

Autosomal recessive hypercholesterolemia (ARH) is a genetic disorder affecting LDL-C levels. Homozygotes show xanthomas and atherosclerosis signs, while heterozygotes have a normal phenotype, suggesting ARH is less severe than familial hypercholesterolemia.

Area of Science:

  • Genetics
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Inherited hypercholesterolemias cause elevated LDL-C and premature heart disease.
  • Autosomal recessive hypercholesterolemia (ARH) results from mutations impairing LDL-receptor activity.
  • This study aimed to detail the phenotypes of ARH homozygotes and heterozygotes.

Purpose of the Study:

  • Characterize the clinical and biochemical phenotypes of individuals with homozygous and heterozygous ARH.
  • Investigate the genetic basis and clinical manifestations of ARH.
  • Differentiate ARH from familial hypercholesterolemia (FH).

Main Methods:

  • Studied 11 ARH homozygotes and 12 heterozygotes from six Italian families.
  • Evaluated lipoprotein profiles, LDL-receptor activity, and performed clinical examinations including ECG and ultrasounds.
  • Analyzed pedigrees for transmission patterns and identified specific ARH mutations (ARH1, ARH2).

Main Results:

  • ARH homozygotes presented with tendinous xanthomas, exertional angina, and signs of atherosclerosis.
  • No ARH homozygotes experienced myocardial infarction or stroke; heterozygotes showed normal lipid profiles and phenotypes.
  • Absence of vertical transmission and presence of consanguinity were noted in pedigrees.

Conclusions:

  • ARH phenotype resembles FH homozygotes but appears less severe.
  • ARH may be diagnosed by absence of vertical transmission and presence of mild coronary heart disease.
  • Heterozygous ARH subjects exhibit a consistently normal phenotype, distinguishing them from FH heterozygotes.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...